Clinical Trials in Nashville

Showing 11961-11980 of 17,403 trials

Efficacy of Micro-excisional Skin Removal by Micro-coring Device in Treatment of Wrinkles and Laxity of Face and Neck

NCT03583918

This is a prospective, multi-center, pilot study evaluating effectiveness of micro-excisional skin remodeling by micro-coring skin in subjects meeting the Inclusion Criteria. Subjects will undergo bilateral treatment on the face and neck (upper and lower cheek, upper and lower lip, periocular and perioral areas, submandibular and middle neck, etc). The exact treatment area(s), choice of treatment density are left to the Investigator's discretion and subject's consent. Up to 3 treatments are allowed with a minimum of 30-day between the consecutive treatments.

Laxity; Skin

Cytrellis Biosystems, Inc.50 participantsStarted Jun 2017

Sacramento, California, United States • Miami, Florida, United States • New York, New York, United States +2 more locations

COMPLETEDPhase 3< 1 mile

Study of the Combination of Rituximab, Cyclophosphamide, Doxorubicin, VELCADE, and Prednisone or Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Newly Diagnosed Mantle Cell Lymphoma

NCT00722137

This is a randomized, open-label, multicenter, prospective study to compare the efficacy and safety of the combination of VcR-CAP to that of R-CHOP in participants who have newly diagnosed mantle cell lymphoma grade II, III or IV and who are ineligible to undergo bone marrow transplantation.

Mantle Cell Lymphoma

Millennium Pharmaceuticals, Inc.487 participantsStarted May 2008

Hartford, Connecticut, United States • Goshen, Indiana, United States • Baltimore, Maryland, United States +147 more locations

Efficacy of Micro-excisional Skin Removal by Micro-coring Device in Treatment of Wrinkles and Laxity of Face and Neck

Study of the Combination of Rituximab, Cyclophosphamide, Doxorubicin, VELCADE, and Prednisone or Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Newly Diagnosed Mantle Cell Lymphoma

Find Trials by Condition in Nashville

Phenotypic Specific Communication Intervention for Children With Down Syndrome

Safety and Tolerability of Intravenous Brivaracetam (Infusion or Bolus) as Adjunctive Antiepileptic Therapy

Radiation Therapy in Treating Patients With Metastases to the Lymph Nodes in the Neck From an Unknown Primary Tumor

Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants

Evaluation of Long-term Safety, and Efficacy of Brivaracetam (BRV) Used as Adjunctive Treatment in Subjects With Epilepsy

Efficacy Evaluation of Intravenous Brivaracetam and Phenytoin in Subjects With Nonconvulsive Electrographic Seizures

Step-up Yellow Zone Inhaled Corticosteroids to Prevent Exacerbations

A Double-blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam in Subjects (≥ 16 to 75 Years Old) With Partial Onset Seizures

Adjustable Continence Therapy (ACT) Device for the Treatment of Female Stress Urinary Incontinence

Clazosentan in Aneurysmal Subarachnoid Hemorrhage

Safety and Effectiveness of the Calhoun Vision Light Adjustable Intraocular Lens (LAL)

The Advocate Study

Evaluation of Safety, Pharmacokinetics and Efficacy of Ceftazidime and Avibactam (CAZ-AVI ) Compared With Cefepime in Children From 3 Months to Less Than 18 Years of Age With Complicated Urinary Tract Infections (cUTIs)

A Single-arm, Open-label, Study to Assess the Pharmacokinetics of Darunavir and Ritonavir, Darunavir and Cobicistat, Etravirine, and Rilpivirine in HIV-1 Infected Pregnant Women

Oxidative Stress Markers In Inherited Homocystinuria And The Impact Of Taurine

MR Guided Focused Ultrasound Surgery in the Treatment of Uterine Fibroids

Intake Promoting Effects of Large Portions in Children

Pharmacist-led Group Medical Visits to Help With Diabetes Management